Government News

The World Health Organization (WHO) and the Government of India today signed an agreement to establish the WHO Global Centre for Traditional Medicine. This global knowledge centre for traditional medicine, supported by an investment of USD 250 million from the Government of India, aims to harness the potential of traditional medicine from across the world through modern science and technology to improve the health of people and the planet.

India has a high burden of Tuberculosis, recording close to 2.64 million cases and 75,000 plus deaths in 2019. A considerable percentage of these cases come from underdeveloped, remote areas without proper access to healthcare services. It is a huge challenge to triage, screen, and monitor it promptly, and at scale, with minimal resources.

The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical Devices, 2022, inviting feedback and remarks of the Industry and stakeholders, till the 25th of March 2022.  In line with the mandate of promoting aspects of the medical device industry, the Department of Pharmaceuticals, realising the need to have a holistic policy to accelerate growth and explore the potential of the Medical Devices Sector, has published thiz approach paper, after extensi

Pharmacy Council of India has mandated exit exam for D.Pharm candidates to register as pharmacist under section 12 of the Pharmacy Act, 1948. No person shall be registered as a Diploma in Pharmacy Exit Examination candidate unless he has passed Diploma in Pharmacy course from an institution approved by the PCI.

Government eases the norms of manufacturing, stocking, sale or distribution of new drugs under phase III clinical trials, for the treatment of Covid-19 and related diseases. The provision is made to stock the drugs with a condition that it will sell the new drug only after obtaining permission as per the regulations.

Lucknow based national laboratory CSIR-Central Drug Research Institute (CDRI), has licensed the technology of Nucleic Acid Staining Dye GreenR to GenetoProtein Pvt. Ltd., a start-up company registered in Uttar Pradesh in the year 2020. This startup is involved in developing an array of enzymes, kits and biochemical used in Lifesciences research, particularly molecular biology. The dye GreenR™ has been developed by CDRI Senior Principal Scientist Dr. Atul Goel in a joint collaborative project with an industry partner Biotech Desk Pvt. Ltd., Hyderabad.

A team of scientists has developed a new technology, platform for fluorometric detection of pathogens such as viruses by measurement of fluorescent light emitted. The potential of the new technology has been demonstrated for the detection of SARS-CoV-2. This technology platform can also be used to detect other DNA/RNA pathogens such as HIV, influenza, HCV, Zika, Ebola, bacteria, and other mutating/evolving pathogens.

The National Health Authority (NHA) under its flagship scheme of Ayushman Bharat Digital Mission (ABDM) announced completion of 27 major integrations across Government and private sector. These integrations with organizations offering Health Management Information Systems (HMIS), Laboratory Management Information Systems (LMIS), health locker services, health tech services and other digital services are a step towards developing a user-inclusive, integrated and interoperable digital healthcare eco-system for the country.

Central Drug Research Institute (CDRI) provides exclusive licensing to Aveta Biomics, USA of its patented technology of Caviunin-based drug compositions for further clinical development and commercialization.

Worldwide, one in three women and one in five men over the age of 50 years will suffer an osteoporotic fracture. In the US alone, an estimated 10 million people over the age of 50 years have osteoporosis and one in two women in the United States will sustain a fragility fracture in her lifetime.